You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 1, 2024

Durlobactam sodium; durlobactam sodium; sulbactam sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for durlobactam sodium; durlobactam sodium; sulbactam sodium and what is the scope of freedom to operate?

Durlobactam sodium; durlobactam sodium; sulbactam sodium is the generic ingredient in one branded drug marketed by Entasis Therap and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Durlobactam sodium; durlobactam sodium; sulbactam sodium has seventy-seven patent family members in forty-two countries.

One supplier is listed for this compound.

Summary for durlobactam sodium; durlobactam sodium; sulbactam sodium
International Patents:77
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
DailyMed Link:durlobactam sodium; durlobactam sodium; sulbactam sodium at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for durlobactam sodium; durlobactam sodium; sulbactam sodium
Generic Entry Date for durlobactam sodium; durlobactam sodium; sulbactam sodium*:
Constraining patent/regulatory exclusivity:
GENERATING ANTIBIOTIC INCENTIVES NOW
Dosage:
POWDER;INTRAVENOUS

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Anatomical Therapeutic Chemical (ATC) Classes for durlobactam sodium; durlobactam sodium; sulbactam sodium

US Patents and Regulatory Information for durlobactam sodium; durlobactam sodium; sulbactam sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Entasis Therap XACDURO (COPACKAGED) durlobactam sodium; durlobactam sodium; sulbactam sodium POWDER;INTRAVENOUS 216974-001 May 23, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Entasis Therap XACDURO (COPACKAGED) durlobactam sodium; durlobactam sodium; sulbactam sodium POWDER;INTRAVENOUS 216974-001 May 23, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Entasis Therap XACDURO (COPACKAGED) durlobactam sodium; durlobactam sodium; sulbactam sodium POWDER;INTRAVENOUS 216974-001 May 23, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Entasis Therap XACDURO (COPACKAGED) durlobactam sodium; durlobactam sodium; sulbactam sodium POWDER;INTRAVENOUS 216974-001 May 23, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Entasis Therap XACDURO (COPACKAGED) durlobactam sodium; durlobactam sodium; sulbactam sodium POWDER;INTRAVENOUS 216974-001 May 23, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for durlobactam sodium; durlobactam sodium; sulbactam sodium

Country Patent Number Title Estimated Expiration
Malaysia 196240 COMBINATION THERAPY FOR TREATMENT OF RESISTANT BACTERIAL INFECTIONS ⤷  Try a Trial
Serbia 58429 KOMBINOVANA TERAPIJA ZA LEČENJE REZISTENTNIH BAKTERIJSKIH INFEKCIJA (COMBINATION THERAPY FOR TREATMENT OF RESISTANT BACTERIAL INFECTIONS) ⤷  Try a Trial
Poland 2834239 ⤷  Try a Trial
Dominican Republic P2014000212 COMPUESTOS INHIBIDORES DE BETA-LACTAMASAS ⤷  Try a Trial
Philippines 12014502224 HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.